KemPharm Analyst Ratings
Benzinga Analyst RatingsNov 17, 2022 19:26
Cantor Fitzgerald Initiates Coverage On KemPharm With Overweight Rating, Announces Price Target of $20
Benzinga Real-time NewsNov 17, 2022 19:25
H.C. Wainwright Reaffirms Their Buy Rating on KemPharm (KMPH)
TipRanksNov 14, 2022 19:25
No Data